Why the study?
How do VEGF kinase inhibitors cause hypertension?
Population
Patients receiving VEGF kinase inhibitors for cancer treatment
Design
Review
Authors
Loading...
Requires vigilant BP monitoring during VEGF inhibitor therapy; extends mechanistic insights but leaves targeted interventions unproven.
How do VEGF kinase inhibitors cause hypertension?
Understanding the mechanisms of VEGF kinase inhibitor-induced hypertension is crucial for developing appropriate therapeutic strategies for cancer patients requiring long-term treatment.
Pankaj Bhargava (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: